Burning Rock and Abbisko Therapeutics Announce Strategic Partnership on Co-development of Companion Diagnostics for ABSK091

NEXT STORY
Global clinical trials market was valued at USD51.25 billion in 2020 and is anticipated to reach USD77.20 billion by 2026
PREV STORY
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor

Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...

author_avatar
NASDAQ Market News

Global Respiratory Care Devices Market Sees Demand Surge in Wake of COVID-19 Pandemic

author_avatar
NASDAQ Market News

NextCure Announces New Appointments to its Board of Directors

author_avatar
NASDAQ Market News